Shirley S. Ong
Hematology Oncology
5115 Centre Avenue, Hillman Cancer Center
Pittsburgh, PA 15232
Pittsburgh, PA 15232
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Journal: Nature medicine
Published: August 20, 2022
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma.
Journal: Biomedicines
Published: June 29, 2022
Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma.
Journal: Journal of neuro-oncology
Published: October 21, 2021
Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDHwt glioblastoma.
Journal: Neuro-oncology advances
Published: October 20, 2021
Targeted Therapy for BRAF Mutant Brain Tumors.
Journal: Current treatment options in oncology
Published: July 16, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis.
Journal: Neuro-oncology advances
Published: July 14, 2021
The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study.
Journal: Neuro-oncology practice
Published: March 05, 2021
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis.
Journal: Neuro-oncology advances
Published: November 05, 2020
Management of gliomas in patients with Lynch syndrome.
Journal: Neuro-oncology
Published: October 15, 2020
False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences.
Journal: American journal of clinical oncology
Published: September 05, 2020
Last Updated: 09/26/2026